TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague.
about
Protecting against plague: towards a next-generation vaccineMutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccinesDirect neutralization of type III effector translocation by the variable region of a monoclonal antibody to Yersinia pestis LcrVTNFα and IFNγ but not perforin are critical for CD8 T cell-mediated protection against pulmonary Yersinia pestis infection.Multiple roles of Myd88 in the immune response to the plague F1-V vaccine and in protection against an aerosol challenge of Yersinia pestis CO92 in mice.Evaluation of imipenem for prophylaxis and therapy of Yersinia pestis delivered by aerosol in a mouse model of pneumonic plagueHSP70 domain II of Mycobacterium tuberculosis modulates immune response and protective potential of F1 and LcrV antigens of Yersinia pestis in a mouse model.IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.YopP-expressing variant of Y. pestis activates a potent innate immune response affording cross-protection against yersiniosis and tularemia [corrected].Yersinia pestis YopE contains a dominant CD8 T cell epitope that confers protection in a mouse model of pneumonic plagueAdvanced Development of the rF1V and rBV A/B Vaccines: Progress and Challenges.Intranasal administration of an inactivated Yersinia pestis vaccine with interleukin-12 generates protective immunity against pneumonic plagueInduction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205/CD205 receptorPlague vaccines: current developments and future perspectives.The role of immune correlates and surrogate markers in the development of vaccines and immunotherapies for plague.Fibrin facilitates both innate and T cell-mediated defense against Yersinia pestis.Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.Immunology of Yersinia pestis Infection.Multiple antigen peptide containing B and T cell epitopes of F1 antigen of Yersinia pestis showed enhanced Th1 immune response in murine model.Immunisation of two rodent species with new live-attenuated mutants of Yersinia pestis CO92 induces protective long-term humoral- and cell-mediated immunity against pneumonic plague.Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia.
P2860
Q26823422-835E7F38-8EB9-4905-A254-EBD45D57A115Q28678943-DAB9216B-5066-45BB-9135-9814F43E96BDQ33601814-4BCE301C-E9F7-43EB-BB11-0122E9EEEAD0Q33650538-0A346A7B-B9CE-4FA6-9912-99FCC0C5D662Q33786763-FA0DF726-2C63-4A6C-BCF8-230939EA5BD0Q33798021-9C925B10-88DB-4695-A0A9-A9DB18B3246FQ34633478-ACD591BC-E906-4124-A2F8-667B67C94DD4Q34786724-22BADAEA-E89E-452B-97AE-368773C9E427Q35073117-669520B8-0509-4D90-8B2F-F58F78D42F21Q35091255-8A3BC6B3-2B99-42B1-9BE2-4623DB2306B6Q35418294-9549597F-ED19-4786-B733-F1DB0CC5A39FQ35530270-DA37E059-B073-42A9-A344-0EDFF3A8791BQ36288336-C58EA66C-03CB-4991-AF72-DF03E54B8FB8Q38514208-925C6EAD-BC6E-47DF-A857-811663B8ECE7Q38589273-28C36441-3A1A-430A-BBDC-207DB0B2D22FQ39736724-EA017B8B-5A11-4A4B-8B88-B71150CCDCD7Q40485593-3E82786D-826C-4396-BE9E-0230A8DD5DDCQ40512106-6F0788ED-2692-40F5-804F-931FF26450F2Q41400297-A55FEF35-5C78-43EA-A319-2A2EED2A4C2DQ47293934-FD242F45-888E-4140-9032-F8D6B758DAF6Q55361721-D27D2000-1DFE-48F7-9940-B888F8EC8D27
P2860
TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
TNFα and IFNγ contribute to F1 ...... lly virulent pneumonic plague.
@ast
TNFα and IFNγ contribute to F1 ...... lly virulent pneumonic plague.
@en
TNFα and IFNγ contribute to F1 ...... lly virulent pneumonic plague.
@nl
type
label
TNFα and IFNγ contribute to F1 ...... lly virulent pneumonic plague.
@ast
TNFα and IFNγ contribute to F1 ...... lly virulent pneumonic plague.
@en
TNFα and IFNγ contribute to F1 ...... lly virulent pneumonic plague.
@nl
prefLabel
TNFα and IFNγ contribute to F1 ...... lly virulent pneumonic plague.
@ast
TNFα and IFNγ contribute to F1 ...... lly virulent pneumonic plague.
@en
TNFα and IFNγ contribute to F1 ...... lly virulent pneumonic plague.
@nl
P2093
P2860
P1433
P1476
TNFα and IFNγ contribute to F1 ...... ully virulent pneumonic plague
@en
P2093
Christopher K Cote
David S Perlin
James B Bliska
Jr-Shiuan Lin
Kei Amemiya
Stephen T Smiley
Steven Park
P2860
P304
P356
10.1016/J.VACCINE.2010.08.099
P407
P577
2010-09-15T00:00:00Z